{"url":"https://lda.senate.gov/api/v1/filings/7f2e2dfd-2bcd-41d9-911d-27632165474e/","filing_uuid":"7f2e2dfd-2bcd-41d9-911d-27632165474e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/7f2e2dfd-2bcd-41d9-911d-27632165474e/print/","filing_document_content_type":"text/html","income":"40000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"PETER REINECKE","dt_posted":"2024-10-09T13:03:34-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"6107 Ridge Drive","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Bethesda","registrant_state":"MD","registrant_zip":"20816","registrant":{"id":298012,"url":"https://lda.senate.gov/api/v1/registrants/298012/","house_registrant_id":37584,"name":"REINECKE STRATEGIC SOLUTIONS, INC.","description":"Policy and communications consulting","address_1":"6107 Ridge Drive","address_2":null,"address_3":null,"address_4":null,"city":"Bethesda","state":"MD","state_display":"Maryland","zip":"20816","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PETER REINECKE","contact_telephone":"+1 703-785-6786","dt_updated":"2026-07-22T14:41:33.192681-04:00"},"client":{"id":179856,"url":"https://lda.senate.gov/api/v1/clients/179856/","client_id":63,"name":"PHARMAVITE LLC","general_description":null,"client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-11-25"},"lobbying_activities":[{"general_issue_code":"FOO","general_issue_code_display":"Food Industry (safety, labeling, etc.)","description":"Improving the regulation of dietary supplements. H.R. 9029/S.4690 Agriculture and Related Agencies Appropriations Act for FY25 Specifically for adequate funding for regulation of dietary supplements. H.R. 4794/S.3177, giving consumers with HSA or FSA the ability to use account funding for the purchase of certain dietary supplements. S.4287, Dietary Supplement Listing Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":9270,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"REINECKE","suffix":null,"suffix_display":null},"covered_position":"LD, CoS, Sr. Advisor, Sen. Harkin","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 9029/S.4690, Agriculture and Related Agencies Appropriations Act for FY25 specifically for adequate funding for regulation of dietary supplements. H.R. 9020/S.4942FY 2025 Appropriations for Department of HHS, specifically for adequate research and education about menopause and women's health.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":9270,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"REINECKE","suffix":null,"suffix_display":null},"covered_position":"LD, CoS, Senior Advisor, Sen. Tom Harkin","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"H.R. 4794/S.3177 giving consumers with HSA or FSA the ability to use account funding for the purchase of certain dietary supplements.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":9270,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"REINECKE","suffix":null,"suffix_display":null},"covered_position":"LD, CoS, Sr. Advisor, Sen. Tom Harkin","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R. 9027/S.4690 Agriculture and Related Agencies Appropriations Act for FY25,specifically for adequate funding for regulation of dietary supplements. FY 2025 Appropriations for Department of HHS (H.R. 9020/S.4942)specifically for adequate research and education about menopause and women's health.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":9270,"prefix":null,"prefix_display":null,"first_name":"PETER","nickname":null,"middle_name":null,"last_name":"REINECKE","suffix":null,"suffix_display":null},"covered_position":"CoS, LD, Senior Advisor Senator Tom Harkin","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}